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 1.            AIM OF THE STUDY 
 
 
1. Comparison of On Board Imager [OBI] versus Cone Beam Computed 
Tomography [CBCT] in the verification of positional accuracy in pelvic 
malignancies in patients undergoing high precision Image gated intensity 
modulated radiotherapy [IG-IMRT] 
 
 
 
2.  Quantification and comparison of total, systematic and random errors in the 
mediolateral [x], craniocaudal [y] and antereoposterior [z] directions to help 
define the clinical target volume [CTV] to planning target volume [PTV]. 
 
 
 
 
 
3. To analyze the time trend in pelvic malignancies during Intensity Modulated 
Radio Therapy (IMRT) which may enable to reduce the number of Cone 
Beam Computed Tomography (CBCT) done in later weeks of radiotherapy. 
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 INTRODUCTION 
 
  Radiation Therapy aims to deliver successfully the prescribed dose of radiation to the tumor 
while sparing the adjacent sensitive normal tissues. 
 
As a result of the recent advances in the field of radiation oncology we have now entered the 
era of high precision radiation therapy such as intensity-modulated radiotherapy (IMRT) and 
image-guided radiotherapy (IGRT). These allow conformal treatment of tumor and conformal 
avoidance of normal tissues leading to improved tumor control and decrease in treatment- 
 
Patient immobilization, tumor volume delineation, organ motion control and dose delivery 
verification are important factors in determining accurate delivery of treatment. These issues 
can decrease geographical miss and in turn provides increased local control and improves 
patient’s outcome. The accuracy of the set up is the main concern to ensure delivery of the 
prescribed dose during treatment and to gain the desired tumor control probability (1).  
 
However, many error sources exist from treatment preparation to execution that limits the 
accuracy of the treatment. As a result a safety margin is required to ensure that the planned 
dose is actually delivered to the target for all patients.  
 
The important errors are Systematic Errors which occur during the initial set up and 
immobilization and persists until treatment delivery leading to a systematic organ motion 
error (1) and Random Errors are deviations between fractions, which are a result of day to 
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day variation in patient position and organ motion or otherwise called treatment execution 
errors(1). 
 
Imaging prior to and during treatment plays a vital role in ensuring an accurate set up and in 
quantifying a safety margin to the clinical target volume  to ensure that the target receives the 
actual dose (2). 
This study aims to quantify and compare these errors using two modalities of imaging namely 
the Kilo Voltage Cone Beam Computed Tomography and the On Board Imager on patients 
who have a pelvic malignancy undergoing Intensity Modulated Radio Therapy, thus enabling  
to determine the required set up margins and positional accuracy during treatment. 
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2. LITERATURE REVIEW  
 
2.1. HISTORY OF RADIOTHERAPY 
 
Radiation Therapy field began shortly after the discovery of X-rays in 1895 by Wilhelm 
Rontgen. The following year, in 1896, Antoine-Henri Becquerel discovered the property which 
came to be known as Radioactivity.  Building on the work of Becquerel, Pierre and Marie Curie 
discovered the radioactive elements Polonium and Radium (3).The field of radiation therapy 
grew quickly in the early 1900s largely due to the groundbreaking work of Nobel Prize-winning 
scientists Antoine-Henri Becquerel, Marie Curie and Pierre Curie. 
Although promising as a therapeutic modality, the important limitation of the early X-ray 
machines to produce high energy, deeply penetrating beams was present. Therefore treatment of 
deep-seated tumors without excessive skin reactions was difficult(4). 
In the 1960s, megavoltage treatment machines, known as Linear Accelerators were introduced 
which were capable of producing high energy, deeply penetrating beams, allowing treatment of 
deep seated tumors without excessive damage to the overlying skin and other normal tissues. In 
the 1970s and 1980s new imaging technologies, including magnetic resonance imaging (MRI) 
position emission tomography (PET) moved radiation therapy from 3-D conformal to intensity-
modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT)(5).These 
advances have resulted in better visualization and targeting of the tumor resulting in better 
treatment outcomes, organ preservation and fewer side effects. 
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In 1993 the invention on the Multi Leaf Collimators [MLC] helped in delivering intensity 
modulated beams lead to the era of IMRT. These leaves were made up of tungsten alloy and each 
leaf width was equal to or less than a centimeter. These aided in delivering IMRT by a) multi-
segmented static field delivery b) Dynamic delivery c) Intensity modulated arc therapy(6). 
The multileaf collimator led to the era of Tomotherapy which used multileaf intensity 
modulating collimator [MIMiC]. This helped in treating the patient slice by slice as the couch 
moved continuously as in a helical CT scan(7). 
 
2.2. HIGH PRECISION RADIOTHERAPY 
 
Intensity modulated radiotherapy [IMRT] is a radiation treatment technique with multiple 
beams incident from different directions in  which at least some of the beams are intensity 
modulated  so that each beam intentionally delivers a non-uniform dose to the target (8). 
It allows concave dose distributions and dose gradients with narrower margins than those 
possible using conventional methods thus avoiding close proximity organs at risk that may be 
dose limiting and provides increased tumor control through an escalated dose (9). In comparison 
with 3D conformal radiotherapy it has been proved to provide better dose distributions in some 
malignancies (10). 
 
Image-guided radiation therapy represents a making of recent technological advances in medical 
imaging and conformal radiation therapy. The principle behind image-guided radiation therapy is 
acquisition of serial images using a variety of medical imaging techniques including computed 
tomography, ultrasound and magnetic resonance imaging. The current interests like positron-
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emission tomography are additional functional imaging which augments these anatomic and 
volumetric image datasets. This ‘adaptive’ radiotherapy helps to recognize change in position of 
tumors and normal tissues during the course of treatment. As the position of the tumor and 
normal tissues change, the attenuation of radiation beams passing through these also change, 
causing an additional level of imprecision in targeting the tumor (11).
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2.3. PROCESS AND THE STEPS IN IMRT  
 
2.3.1. POSITIONING: The position of the patient has to be maintained throughout the whole 
process of preparation, planning and treatment. This position will have to be comfortable as all 
these processes last for 15-30 min. 
 
2.3.2. IMMOBILISATION 
 Reducing the patient movement and internal organ motion is critical for IMRT, as the dose 
distribution can be sculpted closer to the tumor volume and the organ at risk with rapid fall off 
outside the volume. Therefore it is very important that immobilization and reproducibility of 
patient are reconfirmed prior to the implementation of the treatment. The different 
immobilization devices used are alpha cradle, Vac-Loc system and pelvic board with aquaplast 
for pelvic tumors. 
Patient marking, is usually done with permanent tattoos on the skin which allow easy positioning 
of the patient during treatment. Lasers are used during simulation and treatment to assist in 
patient positioning which also allow for accurate determination of the mechanical isocentre. 
 
2.3.3. CT SIMULATION 
Acquire a planning CT scan in the treatment position which is referred to as CT simulation. An 
important point to note is that the CT image set acquired with the patient in the treatment 
position on a flat couch which should be   geometrically identical to the couch on which the 
patient will ultimately be treated. 
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2.3.4. TUMOUR DELINEATION 
 
2.3.4.1. Image registration 
 
The image registration is considered an important part of the IMRT process since it  
a) aids in finding the transformation [translation, deformation and rotation] that maps one scan to 
another 
 b) helps in fusion of scans  
c) used to align rigid structures. 
Fusion of scans 
This strategy combines physiological measurements or tissue characterization from nuclear 
medicine with the anatomic data from radiology or two radiological imaging.The fusion software 
calls for two sets of data for the one patient. One is selected as the “primary” to which the other 
would be registered. Since the two scans have been acquired at different times, in different 
machines and in different positions there would be a difference in slice thickness, pixel sizes and 
size acquisitions. The necessary adjustments are made for registration taking into account the x, 
y and the z coordinates.  
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FIG 2-1: CT Fusion with MRI 
  
Computed Tomography has played a key role in conformal radiotherapy. It has many advantages 
like high spatial resolution and spatial integrity, excellent bony structure depiction and also 
providing the relative electron density information for calculating the radiation dose. CT scans 
have also been used as a verification device during treatment execution. 
 
Magnetic Resonance Imaging [MRI] has the advantage of providing excellent soft tissue 
discrimination which helps in better diagnosis and tumor delineation. It can be used in the 
clinical setting by using the fusion technique with CT for better tumor delineation. Fast cine MRI 
are also being made available which can help as an alternative for imaging the process of 
patient’s breathing or cardiac rhythm. There have been also some developments like diffusion 
and perfusion MRI, Dynamic MRI, MR spectroscopy, MR angiography and functional MRI (5). 
 
Positron Emission Tomography [PET] has been shown to be useful in studying the metabolic 
activity of tumors in vivo.Some initial studies have been reported where FDG-PET has been 
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incorporated into treatment planning and some recommendations have been formed(12,10). 
There have been pitfalls such as the FDG tracer being taken up non specifically by some benign 
conditions like brownfat, granulomatous diseases, pneumonia, inflammatory pathologies, muscle 
and bowel.The recent development of other tracers like flurothymidine [FLT] have been useful 
in increasing the sensitivity and specificity of PET(11). 
New modalities like biological conformal radiotherapy [BCRT] are being introduced where the 
aim was to take in homogenous biological information which is derived from biological imaging 
into account and produce customized dose distribution which are non uniform on a patient 
specific basis(8). 
2.3.4.2. Delineation of tumor and organs at risk  
 
Tumor volumes are delineated on the CT scan meeting the requirements of ICRU 50 and 62. The 
gross tumor volume (GTV) is the gross palpable/ visible/demonstrable extent and location of the 
malignant growth. The GTV consists of primary tumor (GTV-T), metastatic lymphadenopathy 
(GTV-N), or other metastases (GTV-M).  
The clinical target volume (CTV) is the tissue volume that contains a demonstrable GTV and is 
considered to contain microscopic, subclinical extensions of the tumor.  
The ITV [Internal Target Volume} was defined as the CTV plus a margin taking into account the 
uncertainties in shape, size and the  position of the CTV within the patient. Such a margin was 
called the Internal Margin (IM). For example, respiration, variable filling of the bladder and 
rectum and movements of the bowel(13). 
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A set-up margin (SM) is needed to account specifically for various uncertainties and variabilities 
in the reproducibility of patient positioning and inaccuracies in the alignment of the therapeutic 
beams during treatment planning and throughout treatment. The various factors like variations in 
positioning of patient , lack of reproducibility of the equipment (e.g. sagging of gantry, 
collimators, and couch) and human factors (e.g. experience of the radiotherapists and 
technologists). 
The combined effect of an internal margin and a set-up margin to the CTV leads to planning 
target volume (PTV). The planning target volume (PTV) is a geometric concept, created to make 
sure the prescribed dose is delivered to the CTV. 
Organs at risk (OAR) are normal tissues which are highly radiosensitive and could greatly 
influence the treatment planning. 
An integrated margin which is added to the organ at risk to compensate for the variations and 
uncertainties is defined as the planning risk volume (PRV). The use of PRV has enabled IMRT 
planning with improved reduction of dose to critical structures(13). 
 
 
 
 
 
 
Fig 2.2.ICRU 
Volumes 
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2.4 PLANNING 
2.4.1 Selection of treatment beams: 
It is based on a combination of standard protocols, patient anatomy and experience of the 
planner. Selection of optimum beam directions has an effect on the required degree of intensity 
modulation within each field.  
  
2.4.2. Dose prescription and constraints: 
The prescription dose to the target and specified tolerance dose to the normal tissues are 
provided. 
 
2.4.3. Plan optimization: 
After the planner specifies the desired dose limits to the target and the normal organs at risk the 
computer optimizes the combination of   dose intensity pattern of beams. The success of an 
optimization is based on the “cost function”, which is the mathematical definition of the 
goodness of the treatment plan.  
 
2.4.4. Plan Evaluation: 
The plan is then evaluated based on planar dose distributions and dose volume histograms. If the 
dose distribution does not meet the clinical goals of treatment, the optimization parameters   or 
the beams are adjusted and the process is repeated.  
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2.4.5. Quality Assurance: 
 
The various factors of concern in an IMRT that need physics quality assurance will be the 
mechanical tests of the multileaf collimators, dosimetric measurements required for acceptance 
testing and commissioning and the tests specific to each individual patient’s plan. Verification of   
the calculated monitor units and individual field intensity maps before treatment delivery is 
crucial. 
Quantitative or quality individual field checks may be performed using film, EPID or diode 
arrays. Quantitative checks are done to ensure that the intensity map is correctly delivered. 
Printed isodoses can be used to compare the measured and predicted dose distributions (18).The 
gamma index an electronic format is used which examines how best the distributions agree with 
respect to dose difference and distance to agreement within the specified acceptance criteria 
(18,19). Since they were time consuming it led to the development of graphics based processing 
unit [GPU] based gamma index for fast calculations (20). 
Qualitative checks are used to verify that the correct fields are being delivered or to monitor the 
reproducibility. A variety of phantoms can be used to verify the entire treatment delivery using 
different measuring devices like themoluminescent dosimeter, ion chambers and films. Monte 
Carlo codes for the entire treatment verification have been developed recently (21). 
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2.5. VERIFICATION OF PATIENT POSITION 
Orthogonal images are used for verifying the isocenter in conformal radiotherapy. The reference 
images used can be either simulator images or digitally constructed radiographs. To perform 
accurate field matching, field sizes are chosen according to the appropriate anatomy (22).   
 
 
2.6. TREATMENT DELIVERY  
Intensity modulated radiotherapy is delivered with dynamic modulation using a multileaf 
collimator. This being computer based can be delivered as multisegmented  static fields, dynamic 
fields or intensity modulated arc therapy (14).  
 
2.7. MODALITIES OF POSITION VERIFICATION 
In IMRT there are uncertainties exist in tumor target definition, immobilization of patient and 
physiological functions of the patient such as breathing, swallowing etc which make it difficult 
to administer high radiation to the planned target. 
This led to the concept of Image guided intensity modulated radiotherapy which  uses several 
methods for target localization like ultrasound, implanted fiducial markers, Megavoltage or Kilo 
voltage x-rays, optical tracking systems, in room CT scans [Kilo voltage CT on rail], Kilo 
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voltage or megavoltage cone beam CT and helical megavoltage CT which could be used to 
measure and correct errors that occurred prior or during the treatment delivery(20). 
IG-IMRT plays an important role in eliminating or reducing the margins involved in defining the 
CTV and PTV(16, 17). 
In the early days radiographic films were used for acquiring images for treatment verification 
which had its disadvantages that it required processing and also had a fixed dynamic range and 
digitization which made it impossible to use for online imaging and also required storage space. 
In the 1980’s computed radiography came into light but had similar disadvantages as that of the 
films. 
Electronic  portal imaging devices [EPID] have been in the process of development for many 
years and was first introduced in the 1950’s.The technology has developed over the years which 
could be broadly classified as camera based systems, ionization matrix devices, scanning array 
and other systems like flat panel devices and amorphous silicon devices. Obtaining rapid high 
quality images and flexibility in computer digitization helps in online corrections and thereby 
reduces set up errors. The x-ray image transducer panels using Selenium and amorphous Silicon 
[aSi] was an improvement in the EPID technology despite its disadvantages of employing 
megavoltage imaging. However these flat panel inducers provided the basis for the practical 
implementation of imaging with Kilo voltage x-rays which is being developed as the imaging 
technology of the new era in conformal radiotherapy(23,24). 
 
 
  
21 
 
2.7.1. KILOVOTAGE IMAGING         
The use of Kilo voltage [KV] x-ray imaging for set up verification is historical. In the 1950s the 
cobalt-60 unit had a separate KV x-ray system attached to it. By the mid 1980s Biggs et al, (23) 
introduced the KV source mounted on a medical accelerator Shiu et al in 1987(24) introduced 
the set up verification by using cobalt -60 treatment beams with a KV gantry mounted source on 
the film to yield better quality images. Cho and Munroe in 2002 (25) introduced the design of the 
new x-ray target which produced both KV and megavoltage [MV] beams. Akoi et al  (25) 
developed the integration of a CT scanner with a medical accelerator in the treatment room with 
a communal couch and software utilities. In 1995 Jaffray et al  (11) described an imaging system 
which was dual beam consisting of KV and MV imaging systems. There was a KV source 
mounted at 45 degrees from the MV source and a shared CCD imaging device. This system 
rapidly evolved and was also capable of tomographic imaging using cone beam CT scan. In 1999 
Jaffray, Drake et al (11) developed it into a device with dual sources mounted 90 degrees apart 
and dedicated CCD imaging device for each source. This eventually led to the development of 
the “synergy” accelerator by Elekta Inc which was also available in other commercially similar   
“On Board imager” KV imaging systems by Varian medical systems. 
 
In room KV systems can be broadly classified on the basis of installation as 
 Rail track –mounted system 
 Ceiling/floor- mounted system 
 Gantry-mounted system. 
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ON BOARD IMAGER AND CONE BEAM COMPUTED TOMOGRAPHY 
2.7.1.1. ON BOARD IMAGER 
This KV imaging system consists of 3 robotic arms. The EXaCT arms,  the two 
electronically stabilized arms that hold x–ray tubes [G242] and the high performance flat 
panel imagers and the third identical robotic arm which holds the MV imager. The position 
of the imager of the OBI is set at 50cm below isocenter. It can be moved +0.5cm above 
isocenter to -80cm from the isocenter along the direction of the KV beam. Depending upon 
the source to imager distance it can be moved laterally by +/-16cm and extended 19.5 to 
23cm past the isocenter. The x-ray tube can be positioned at either 80cm or 100cm from the 
isocenter. 
     The EXaCT arms position can be parked, partially extended and in the extended position and                  
can be controlled remotely. The arms can be controlled either individually, as a pair [OBI source 
and imager] or as a triple [OBI plus MV imager]. 
 
 
 32kW X-Ray Generator: 
 Mounted in Gantry Stand (Right Hand Sid) 
 40 – 150 KV range 
  10 – 320 mA  
  
23 
 
 G242 X-ray tube: 
 [KVS] Arm mounted at 270 position 
  0.4 & 0.8mm focal spot sizes 
  14 degree anode angle 
 KV Imager 
  PaxScan 4030CB a-Si panel 
  [KVD] Arm mounted at 90 position 
  ~ 40 x 30cm (landscape) 
The KV X –Ray source is located between 80 and 100cm from the isocenter of the machine 
and the KV source collimator is used for asymmetrical and symmetrical fields with the blade 
position. 
MV Imager 
  Portal Vision a-Si 1000 panel 
  Image Acquisition System [IAS] 
 1024 x 768 pixels at full resolution. 
 
 
The On Board imager is capable of the radiographic and the fluoroscopic mode. 
Fluoroscopy:   
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 It produces pulsed images ms at 15fps.It is taken at a tube voltage range of 40 to 125KV range 
and upto 80mA tube current. 
The uses of fluoroscopy are for pre treatment motion assessment, setup of gating and tracking 
parameters and for intra fraction respiratory tracking and compensation.  
Digital Radiography: 
It is used for general kilo voltage imaging rather than fluoroscopy. It is taken at a tube voltage of 
40-150KV range and a tube current of upto 320mA. The panel pixels read out at high and low 
sensitivities depending on the dual or single gain effect and the system selects which results 
provide more information based on the saturation levels, namely increase in the dynamic range, 
and increase in contrast between bone and soft tissue. The standard resolution for dual gain is 
1024x768 pixels and the high resolution for a single gain effect is 2048x1536 pixels. 
  ADVANTAGES  
 The orthogonal portal images both MV and KV can be acquired without gantry rotation 
for antereoposterior and lateral online set up or for the KV/KV image pair. 
 The couch position and angle can also be corrected based on 2D matching between portal 
images and the digital radiograph images.  
 The advantages of the kilo voltage imaging compared to the megavoltage imaging is that   
 There is better bone and soft tissue contrast 
 Lesser radiation dose 
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 No metal artefacts 
 Fluoroscopic imaging 
 It is not the treatment beam 
 It is not real time imaging  
       RADIATION DOSE OF KILO VOLTAGE PORTAL IMAGING 
   The dose to the rectum from a kilo voltage source was approximately 99% lesser for two          
portal images than that made with megavoltage source a 5MU/exposure. The dose at skin was 
98% lower from a kilo voltage  source(26). 
 
 Figure: 2.2 a & b: KV imaging at 0 and 90 degrees respectively 
             Figure: 2.3 c & d: MV imaging at 0 and 90 degrees respectively 
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2.7.1.2. CONE BEAM COMPUTED TOMOGRAPHY 
Kilo voltage cone-beam computerized tomography (KV- CBCT) systems integrated into the 
gantry of linear accelerators are used to acquire high-resolution volumetric images of the patient 
in the treatment position. Using on-line software and hardware, the position of the patient can be 
determined accurately with a high degree of precision and the set-up parameters can be adjusted 
to deliver the accurate treatment. 
       The capabilities of CBCT include 
 600 to 750 projections 
 370 degree gantry rotation 
 Acquisition time of 65seconds 
 Approximately 2.5minutes totally for acquisition and reconstruction of images 
 Has a beam angle of 14 degrees 
MODES OF CBCT ACQUISITION 
              FULL FAN DETECTOR 
 Detector centered 30 x40 
 Reconstructed field of view at 24cm in diameter 
 15cm in Craniocaudal [C-C] extent 
 Full bow tie used 
 Used for smaller sites 
     
 27 
 
        HALF FAN DETECTOR                                                          
 Detector shifted by 14.8cm 
 Field of view 45cm in diameter 
 14cm C-C extent 
 Half bow tie used 
 Used for larger sites 
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                    Figure: 2.4: CBCT FANS 
 RADIATION DOSE IN CBCT 
Various studies(27) have been done on studying the radiation dose delivered by the kilo voltage 
cone beam computed tomography. There are various factors that influence the radiation dose 
delivered during cone beam CT. Patient related factors like patient size and technical factors like 
kilo voltage, number of frames to reconstruct an image, milli Amperes and time per frame (ms) 
and field size. 
A study on doses of CBCT in prostate cancer(28) showed that the measured antero posterior skin 
dose was lesser for a larger patient but it did not influence the lateral doses much. The left lateral 
doses were approximately 40% higher than the right lateral dose which was justified since the 
 29 
 
KV source rotation started from the left lateral side of the patient and ended on the same side and 
in the 370 degree scan rotation there can be an overlap of 10 degree on the left lateral side.  
In a study done by Dufek et al(29), measurement of organ doses by means of themoluminescent 
dosimeter were performed in a male anthropomorphic Rando phantom from one CBCT scan, two 
MV images and two KV images of pelvis which were  1-6, 1-10 and 0.05-1 %, respectively, of 
the organ doses resulting from one fraction of prostate radiotherapy. The maximum effective 
doses from CBCT scans, KV images and MV images of pelvis were 5.6, 0.8 and 11.9 mSv, 
respectively. 
Study done by Ding et al(30), also showed that the doses of CBCT can be minimized by 
reducing the scan length, the exposure settings, selection of the gantry rotation angles, and also 
by using the full fan bow-tie in the needed situations.  
 
       BASIC APPROACH OF THE OBI AND CBCT 
 To create set up fields and reference images [2D] in database 
 To define the anatomical structures or markers 
 To set up the patient on the couch 
 Acquire 2D/3D image with OBI/CBCT 
 Analyse and match images-determine the shifts 
 Apply the corrective shifts 
 Treatment delivery 
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 2.8. ERRORS 
DEFINITION:  
Error is defined as the difference between the actual and intended position of the part of the 
patient that is irradiated, with respect to the treatment beam(s) during treatment. 
2.8.1. SOURCES OF ERRORS 
According to the ICRU there are three sources of geometrical uncertainty which may interfere 
with the accurate delivery of a treatment plan namely,  
(1) variation in the patient set up like daily positioning of the patient on the couch, 
(2) variations due to organ motion and deformation like bladder or rectum filling variati 
(3) due to machine related errors like beam sizes or gantry which contribute a small part 
compared to the other two causes (27).  
 
 2.8.2. QUANTIFICATION OF SET UP ERRORS 
2.8.2.1. SYSTEMATIC ERRORS 
Systematic Error is the deviation between the planned patient position and average patient 
position over a course of fractionated therapy which is caused due to errors during treatment 
planning. They can be errors in the position of patient during planning CT or errors during target 
delineation. These are called treatment preparation errors.  
 31 
 
2.8.2.2. RANDOM OR INTERFRACTION ERRORS 
Random errors are deviations between different fractions, during a treatment series which are a 
result of day to day variation in patient position and organ motion or otherwise called treatment 
execution errors. 
2.8.3 EFFECT OF ERRORS ON DOSE DISTRIBUTION 
Systematic and Random Errors have different effects on the dose distributions. 
Systematic Errors cause a shift in the cumulative dose distribution relative to the target which 
leads to serious consequences like the CTV shifts out of the high dose region. This can affect all 
fractions (28)  
Random Errors lead to blurring of the dose distribution. They will point in varied directions for 
different fractions which result in a much smaller dose effect as compared to systematic errors. 
This blurring effect causes a small decrease in the dose at the edge of the high dose region which 
can affect the treatment. 
. 
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Figure: 2.5: Systematic and Random Errors  
Systematic errors lead to a shift of cumulative dose distribution relative to CTV & Random 
errors lead to blurring of dose distribution 
 
2.8.4. CALCULATION OF SYSTEMATIC AND RANDOM ERRORS:  
The errors [translational] are measured in 3 directions namely cranial-caudal[CC], anterior-
posterior [AP] and the mediolateral axis [ML]. Cranial-caudal axis is measured from head to the 
feet, mediolateral axis from the left to the right side and the anterior-posterior axis from the 
backside to the front side. Systematic and Random Errors are calculated in each direction 
separately and then mathematically combined to obtain a 3D displacement vector. 
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2.8.5. TIME TRENDS:  
It is defined as the consistent gradual drift in the set up errors during the complete course of 
treatment. Researchers like El Gayed et al(33), 1993 reported significant time trends in set up 
errors in 5 out of 20 patients. Osei et al in 2009(34) studied online correction of set up errors and 
displacement in prostate cancer using gold seeds and imaging with EPID and DRR and 
concluded that there were no significant time trends observed during the course of treatment. In a 
study done on pre-treatment position verification of patients with prostate cancer on high 
precision radiotherapy comparing KV images and CBCT, they were statistically significant 
changes in the time trend for 4 patients among KV results and 3 patients in the CBCT 
results(29).  
2.9. DETERMINATION OF SAFE PTV MARGIN  
To accommodate inter and intrafraction set up errors in patients, the ICRU recommended 
expanding the clinical target volume (CTV) by a margin to obtain the planning target volume 
(PTV).  
Several authors have conducted studies on obtaining the correct CTV to PTV margin both for the 
target as well as for the organs at risk like Stroom et al, (31), Mc Kenzie et al(36). 
The Van Herk model formula [VHMF] assumed both Systematic and Random Errors to be 
normally distributed and the standard deviations (SDs) of Systematic and Random Errors, 
assumed common to all axes, were denoted by Σ and σ. The required margin was given as: M = 
2.5Σ+0.7σ. This formula ensured that 90% of patients experience a CTV minimum dose (after 
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setup errors) which is greater than or equal to the planned PTV minimum. The VHMF was based 
on several assumptions like  
(a) Homogeneous tissue 
(b) A number of fractions that is sufficiently large for the sum of fraction doses to be well-
approximated by a convolution (convolution method) 
 (c) A spherical target that is large compared to the setup errors,  
(d) A normal beam penumbra of width ~0.5 cm and  
(e) An isodoses surface exactly conforms to the PTV, so that any movement of the CTV outside 
the PTV reduces the minimum CTV dose below the planned minimum PTV dose. Studies by 
Gordon et al and Craig et al on prostate, lung and breast malignancies showed that tissue in 
homogeneities have little effect on margins.  
Finite fraction issues were addressed by Van Herk et al(32). Gordon and Siebers(37)and others 
like Craig et al (37) found out that VHMF was inaccurate for sigma more than 0.2 because it 
failed to account for non negligible variability in the dose which were associated with Random 
Errors. When sigma is lesser than egual sigma (P) which is 0.32, variability in dose due to 
random errors becomes negligible, and the convoluted method and VHMF becomes valid 
regardless of the values of sigma and number of fractions [N]. When sigma is greater than or 
approximately egual sigma (P), it was found that the VHMF can underestimate margins for large 
and small sigma and small n. As a consequence of this underestimate, the CTV minimum dose 
can fall below its planned value in more than the prescribed 10% of treatments. So alternative 
algorithms like were developed since they concluded that the VHMF which is based on the 
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convolution method should be used with caution in hypo fractionated or adaptive therapy 
regimens.  
 
Dosimetric margin distribution [DMD] is a new concept for calculating the margins which is 
being evaluated by authors. It is defined as the margin distribution achieved between the CTV 
and the treatment volume [TV]. The sensitivity of the CTV dose to errors in the set up is a 
function of the TV and not the PTV. VHMF identifies TV with the PTV by assuming tight 
conformance of the dose to the PTV, but TV is larger than the PTV which resulted in the 
disagreement between the theory and application of VHMF which led to this concept. 
 
Dosimetric margins extend beyond the CTV-to-PTV margin which results in it 
overcompensating for set up errors and thus achieving a level of target coverage that is higher 
than the specified value. Thus the resulting plans will be able to tolerate larger setup errors.  
 
The dosimetric margin distribution could have the potential to be a useful tool in assessing the 
effects of setup errors on treatment plans and also in modifying the plans so that they are more 
strong with respect to errors(30).   
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3.  MATERIALS AND METHODS 
 
3.1. STUDY DESIGN 
This is a descriptive study comparing the On Board Imager [OBI] versus Cone Beam Computed 
Tomography [CBCT] in the verification of positional accuracy in patients undergoing high 
precision Image Gated Intensity Modulated Radio Therapy [IG-IMRT] for pelvic malignancies. 
Quantification and comparison of total, systematic and random errors in the mediolateral [x], 
craniocaudal [y] and antereoposterior [z] directions were done which in turn help in defining the 
clinical target volume [CTV] to planning target volume [PTV]. 
 
3.2. SAMPLE SIZE 
All the patients who had been diagnosed to have a pelvic malignancy and on IG-IMRT from 
January 2012 to August 2013 were included in the study since it was a descriptive study. 
 
3.3. INCLUSION CRITERIA 
Patients with a pelvic malignancy who were undergoing intensity modulated radiotherapy and 
those who consented for the study were included. 
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3.4. STUDY PROTOCOL 
The protocol described below was used for patients who consented to participate in the study 
 
3.4.1. PRE REQUISITE: 
The study was reviewed and cleared by the Ethics and Research Committee of the Institutional 
Review Board. The patients were explained the details of the study and were given a written 
description of the study. Once they consented and signed the informed consent form, they were 
included in the study. 
.  
 
3.4.2. IMMOBILISATION DEVICE: 
The immobilization device used was Vac-loc or a vacuum bag shaped to the individual’s body 
contour which prevented the movement of the patient during planning and treatment. 
 
 
3.4.3. SIMULATION AND IMAGING: 
After immobilization the patient was simulated in a VARIAN simulator. Three reference points 
were marked on the patient’s body in the treatment field using lasers and were tattooed. A CT 
scan was acquired with 5mm cuts in supine position. Radio opaque markers were placed on the 3 
centers which made it visible in the CT images. Contrast agents are used both orally and 
intravenously for enhancing the quality of the images and for better delineation of lymph nodes 
and bowel.  
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3.4.4. VOLUME DELINEATION: 
The CT images were registered and transferred to the ECLIPSE planning system(version 1.5) 
The Gross Tumor Volume (GTV), Clinical Target Volume (CTV), Planning Target Volume 
(PTV), Organs at Risk (OAR) and Planning Risk Volume of OAR’s (PRV) were delineated in 
each slice of the CT scan according to ICRU 50 and 62 guidelines. A margin of 5mm was given 
to the CTV to obtain the PTV.Dose constraints were provided for the organs at risk. 
 
 
 
 
3.4.5. PLANNING: 
The planning was done on the ECLIPSE treatment planning system version 10.1. 
DRR’s were generated for all the treatment fields and 2 orthogonal images were generated [AP 
and Lateral] for the purpose of treatment verification. Then once the plan was finalized, the 
scheduling of the treatment, assignment of dose limits and rearranging the treatment fields was 
done. Then the images were sent to the treatment unit via ARIA.A quality assurance on the plan 
was done before the initiation of the treatment. 
 
 
 
 39 
 
3.4.6. TREATMENT UNIT 
The treatment used for treating the patients was the Varian CLINAC 2100-C/D.It is dual energy 
treatment unit with 6MV and 15MV and electron energies 4MeV, 6MeV, 9MeV, 12MeV and 
15MeV. It has the facilities for IMRT and IGRT. The maximum field size is 40x40cm. It has 60 
pairs of multi leaf collimators which are made up of tungsten. The 40 pairs in the middle have a 
leaf diameter of 0.5cm and the 20 pairs of leaves on either side have a leaf diameter of 1cm. It 
has the on board imager software which is used for treatment verification.   
 
The 2D-2D matching systems available are the 
 a) kV-kV b) kV-MV c)MV-MV using the On Board Imager. 
The 3D-3D matching system is done using the Cone Beam Computed tomography. The CBCT 
scan consists of a full beam and a half beam CT. In pelvic malignancies the full tie bow filter is 
used in the CBCT. 
 
 
3.4.7. TREATMENT VERIFICATION 
The treatment verification were done on days 1, 2 and 3 and weekly once for the entire duration 
of treatment. The verification was done with an On Board Imager by obtaining antereoposterior 
and lateral images and CT images on a Cone Beam CT scan. 
 
The analysis of the images was done online and displacements beyond the tolerance limits were 
corrected.  
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3.4.8. IMAGE ANALYSIS 
 
Analysis of the images was done after image registration. After mutual intensity based 
registration by OBI the DRR was fused with the OBI image and the CBCT image respectively.  
The 2D-2D matching was done with the help of the virtual cross hairs. The 3D-3D matching was 
done with a) automated gray scale value matching and b) manual matching. 
 
First the 3D matching was done with the automated matching where only a global matching will 
be possible and it is then matched manually according to the anatomy. 
The shifts in all 3 directions were noted and the displacements beyond the tolerance limits were 
shifted accordingly. 
  
3.5. STATISTICAL ANALYSIS 
3.5.1. ERRORS 
The total errors in the three directions [mediolateral, craniocaudal and antereoposterior] were 
measured. Displacements obtained each day were compiled and the following were calculated.  
The Systematic Error [SE] is arrived at by summing up the measured set up error for each 
imaged fraction [1+2+3] and then dividing that by the number of fractions[n]. The Systematic 
Error was calculated for the first 3 days and the patient was shifted accordingly and treated. 
M = [1+2+3] /n 
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The overall population mean set up error [M pop] is the means of each individual patient 
(individual systematic error m1, m2, m3 in x, y and z directions) being summed and the total 
divided by the number of patients in the analysed group[p]. 
Mpop = m1+m2+m3 / p 
The Population Systematic Error [2] is the Standard Deviation of the distribution of the mean 
errors for each individual patient. It is arrived at by summing the squares of the overall 
population mean and the resultant sum is divided by the number of patients  and the square root 
of the resultant value is taken. 
2 = (m1- Mpop)
2
 + ( m2- Mpop)
2
 + ( m3 –Mpop)
2
/ p 
Random Error [] is the Standard Deviation of all the measured errors over the course of 
treatment. It is calculated by summing the squares of set up error from each image in inturn. The 
resultant sum is divided by the number of images and the square root of the resultant value gives 
the individual Random Error. 
The Random Error was calculated from the first week of treatment till the end of treatment. 
2= 1
2 
+2
2  
+3
2
/ n-1 
Population Random Error [2] is the mean of the individual random errors which is taken as the 
mean of all the individual random errors. 
 = 1+2+3+4…….. / p 
The Systematic and the random errors in the mediolateral, craniocaudal and the antereoposterior 
directions measured by the OBI and the CBCT were compared by the Bland Altman plots and a 
paired sample nonparametric test , wilcoxon signed rank test was done to acquire a P value to 
ascertain its significance. 
A  P value  0.05 was considered to be significant in the statistical analysis. 
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3.5.2. 3D VECTOR DISPLACEMENTS OR ERRORS 
The 3 dimensional vector was calculated for the Systematic and the Random components from 
the displacements measured in each direction. It indicates the magnitude of displacement in any 
spatial direction from the reference position. It is calculated using the formula 
D3D =  ( d
2 
ap + d
2
cc + d
2
ml) where the dap ,d cc, dml are the displacements in the antereoposterior, 
craniocaudal and the mediolateral directions respectively. 
3.5.3. CTV TO PTV MARGIN CALCULATION 
The CTV to PTV margins were calculated using three formulas as suggested in literature.  
1. ICRU 62: (Population systematic error [] +0.7 x population random error []) 
2. Stroom’s formula: (2 x population systematic error + 0.7 x population random error) 
3. Van Herk’s Formula: (2.5 x population systematic error + 0.7 x population random       
                                                                                                                              Error) 
Comparison between the two modalities of set up verification [OBI and CBCT] was done using 
the Stroom’s formula. 
A Bland-Altman plot was done to compare the two modalities and the non parametric wilcoxon 
signed rank test was done to ascertain the significance. 
A p value  0.05 was considered to be significant statistically. 
3.5.4. TIME TREND ANALYSIS 
The average total error obtained for all the patients in the mediolateral, craniocaudal and 
antereoposterior directions on the first 3 days and weekly once were plotted against time to see 
the impact of time on displacement for both modalities. 
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4. RESULTS 
All the patients with a pelvic malignancy on IG-IMRT from January 2012 to August 2013 and 
signed the informed consent were enrolled in the study. A total number of 15 patients were 
enrolled in the study. 
During the treatment, each patient had an OBI and CBCT taken on the first 3 days of treatment 
[days 1, 2 and 3] followed by weekly once. The displacements in the antereoposterior, 
mediolateral and the craniocaudal directions were computed and the errors more than the 
tolerance limit [5mm] were shifted and corrected. The Systematic, Random and Radial Errors 
were calculated for both the OBI and the CBCT. 
4.1 PATIENT CHARACTERISTICS 
Sex Number of Patients 
Male 5 
Female 10 
Table 4.1.1: Sex distribution 
Diagnosis Number of Patients 
Carcinoma  Prostate 2 
Carcinoma Cervix 6 
Carcinoma Vagina 1 
Carcinoma  Endometrium 1 
Carcinoma Rectum 5 
 
 
Table 4.1.2: Diagnosis 
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Number of Patients  Energy of beam Dose in cGy Number of Fractions 
1 6MV 4500 25 
2 6/15MV 5000 25 
10 6MV 5040 28 
2 6MV 7640 41 
Table 4.1.3: Treatment Characteristics 
Table 4.1.1 shows that 5 males and 10 females were included in the study and Table 4.1.2 shows 
that the maximum number of patients had gynecological malignancy(8/15), 2 patients had 
carcinoma prostate and 5 had carcinoma rectum. Table 4.1.3 depicts the energy used, dose and 
fractionation of treatment delivered for each patient. 
4.2 ERRORS 
 The two main types of errors are the systematic error and the random errors. The mediolateral 
shift (x), craniocaudal shift (y) and the antereoposterior shift (z) were measured for all patients in 
OBI and CBCT. The radial error or the length of the mean vector displacement was also 
calculated using the Euclidean distance formula for the 3 dimensions x, y and z. The systematic 
and random errors were calculated based on these measured shifts.  
4.2.1 CONE BEAM COMPUTED TOMOGRAPHY 
4.2.1.1:  SYSTEMATIC ERRORS 
Definition: This is the deviation between the planned patient position and average patient 
position over a course of fractionated therapy which is caused due to errors during treatment 
planning. 
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Patient No.              x (cm)              y(cm)              z(cm) Radial Error 
1 0.40 0.30 0.73 0.89 
2 0.13 0.27 0.27 0.40 
3 0.10 0.37 0.23 0.45 
4 0.17 0.07 0.03 0.18 
5 0.37 0.17 0.93 1.02 
6 0.30 0.20 0.17 0.40 
7 0.20 0.20 1.80 1.82 
8 0.33 0.33 0.57 0.74 
9 0.60 0.20 0.20 0.66 
10 0.37 0.40 0.50 0.74 
11 0.20 0.07 0.33 0.39 
12 0.17 0.10 0.23 0.30 
13 0.17 0.03 0.10 0.20 
14 0.53 0.90 0.90 1.38 
15 0.37 0.43 0.43 0.71 
Mean 0.2933 0.2689 0.4956 0.6853 
SD 0.14864 0.21509 0.45545 0.45318 
Minimum 0.10 0.03 0.03 0.18 
Maximum 0.60 0.90 1.80 1.82 
Percentile Quantiles 
25
th
 0.1667 0.1000 0.2000 0.3944 
50
th
[median] 0.3000 0.2000 0.3333 0.6633 
75
th 
0.3667 0.3667 0.7333 0.8876 
Table 4.2.1.1: Systematic Errors in cm in the x, y and z direction and radial errors using CBCT 
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Figure: 4. 1: Systematic Errors measured by CBCT in cm in the x, y and z directions for 
the 15 patients 
 
 
The systematic errors of the CBCT ranged from 0.10 to 0.60cm in the x direction, 0.03 to 0.90cm 
in the y direction and 0.03 to 1.80cm in the z direction respectively. The shift exceeded the 
tolerance in 2 patients in x direction, 1 patient in the y direction and 6 patients in z direction. One 
patient had significant shift in all the three directions. The median shift was within the tolerance 
and 75
th
 percentile exceeded the tolerance only in z direction.  
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Figure: 4. 2: Systematic Errors measured by CBCT in the x direction in cm 
Figure 4.2 shows the histogram of the systematic errors of CBCT in the mediolateral direction 
and the graph shows that most of the errors were within 0.5cm. Two patients had an error of 
more than 0.5cm (0.53 and 0.6cm). 
 
Figure:  4. 3: Systematic Errors measured by CBCT in the y direction in cm  
Figure 4.3 shows the histogram of the systematic errors in CBCT in craniocaudal direction and 
the graph shows that most of the errors were within 0.5cm. Only one patient exceeded the 
tolerance and had an error of 0.9cm. 
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Figure: 4. 4: Systematic Errors measured by CBCT in the z direction in cm  
Figure 4.4 shows a histogram of the systematic errors of CBCT in antereoposterior direction and 
the graph shows that 9 patients had errors within 0.5cm, 5 were ranging from 0.5 to 1cm and 1 
patient had an error of 1.80.   
4.2.1.2 POPULATION SYSTEMATIC ERROR CBCT 
Systematic 
Error 
No of 
Patients 
Overall Population Mean Set 
Up Error [Mpop] 
Population Systematic 
Error  ∑2 
x 15 0.29 0.02 
y 15 0.26 0.04 
z 15 0.49 0.22 
Table 4.2.1.2:Overall Population Mean Setup Error and the Population Systematic Error using 
CBCT: The Population systematic errors were 0.023673, 0.049569 and 0.22225623 cm in the x, 
y and z direction respectively as shown in Table 4.2.1.2. 
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4.2.2 ON BOARD IMAGER 
4.2.2.1 SYSTEMATIC ERRORS 
 
 
Table 4.2.2.1: Systematic Errors in cm in the x, y and z directions and radial errors using the On 
Board Imager. 
Patient No. x [cm] y[cm] z[cm] Radial Error 
1 0.43 0.13 0.63 0.78 
2 0.13 0.40 0.17 0.45 
3 0.10 0.43 0.10 0.46 
4 0.07 0.07 0.03 0.10 
5 0.07 0.13 0.03 0.15 
6 0.00 0.00 0.00 0.00 
7 0.16 0.10 1.30 1.31 
8 0.03 0.23 0.23 0.33 
9 0.50 0.10 0.07 0.51 
10 0.03 0.67 0.37 0.76 
11 0.13 0.03 0.20 0.24 
12 0.37 0.23 0.60 0.74 
13 0.13 0.23 0.30 0.40 
14 0.43 1.10 0.27 1.21 
15 0.70 0.50 0.23 0.89 
Mean 0.2200 0.2844 0.3022 0.5566 
SD 0.2115 0.21509 0.45545 0.45318 
Minimum 0.00 0.00 0.00 0.00 
Maximum 0.70 1.10 1.30 1.32 
Percentile Quantiles   
25
th
 0.0667 0.0667 0.0667 0.2427 
50
th
[median] 0.1333 0.2333 0.2333 0.4558 
75
th 
0.4333 0.4333 0.4333 0.7789 
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Figure: 4. 5: Systematic Errors measured by OBI in cm in the x, y and z directions for all 
15 patients 
 
The systematic errors of the OBI ranged from 0.0 to 0.7cm in the x direction, 0.0 to 1.10cm in 
the y direction and 0.0 to 1.30cm in the z direction respectively as shown in Table 4.2.2.1. The 
shift exceeded the tolerance in 1 patient in x direction, 2 patients in y direction and 3 patients in z 
direction. The median shift and shift in 75
th
 percentile were within the tolerance in all three 
directions. 
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Figure:  4. 6: Systematic errors measured by OBI in the x direction in cm  
The Figure 4.6 shows the histogram of the systematic errors of OBI in the mediolateral direction 
and the graph shows that most of the errors were within 0.5cm. Only one patient had an error of 
0.70m 
 
Figure: 4. 7: Systematic errors measured by OBI in the y direction in cm.  
Figure 4.7 shows the histogram of the systematic errors of OBI in the craniocaudal direction and 
the graph shows that most of the errors were within 0.5cm and two patients who had errors of 
0.67  and 1.10cm. 
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Figure: 4. 8: Systematic errors measured by OBI in the z direction in cm.  
Figure 4.8 shows the histogram of the systematic errors of OBI in the antereoposterior direction 
and the graph shows that most of the errors were within 0.5cm and three patients had an error of 
>0.5cm (0.6, 0.63 and 1.30cm). 
 
4.2.2.2  POPULATION SYSTEMATIC ERROR  OBI 
Systematic 
Error 
No of 
Patients 
Overall population mean set 
up error [M pop] 
Population Systematic 
Error  ∑2 
X 15 0.22 0.05 
y 
 
y 
15 0.28 0.1 
Z 15 0.3 0.12 
 
Table 4.2.2.2: Overall Population Mean Setup Error and the Population Systematic using OBI. 
The Overall Population Systematic Error was 0.05, 0.1 and 0.12 in the x, y and z directions 
respectively as shown in Table 4.2.2.2. 
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4.2.3: COMPARISON OF CBCT AND OBI SYSTEMATIC ERRORS 
 
CBCT Vs  OBCT  Bias [SD]  Limits of Agreement 
[LL, UL] 
     Systematic error(x) 
 
 
 
-0.07[0.19]  [-0.44, 0.30] 
     Systematic error(y) 
 
 
 
0.016[0.15]  [-0.28, 0.31] 
Systematic error(z) 
 
 
 
-0.20[0.31]  [-0.80, 0.41] 
Table 4.2.3.1: Shows the Bias and the limits of agreement between the OBI and CBCT 
systematic errors. 
The Bland-Altman plot was used for the comparison between the two modalities, in which the 
differences are plotted against the averages of the two modalities. Horizontal lines are drawn at 
the mean difference, and at the limits of agreement which are defined as the mean difference plus 
and minus 1.96 times the standard deviation of the differences. 
 
Figure: 4. 9: The Bland-Altman plot between the CBCT and OBI in the x direction. 
In Table 4.2.3.1 and Figure 4.9 the Bland–Altman plot for the systematic error in the x direction 
showed a bias of -0.07 with an agreement limit of (-0.44, 0.30). This suggests that the CBCT and 
OBI do not have a good agreement with each other and there is 1 patient who is not within the 
limits. 
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Figure: 4. 10: The Bland-Altman plot between the CBCT and OBI in the y direction  
In Table 4.2.3.1 and Figure 4.10 the Bland–Altman plot for the systematic error in the y direction 
showed a bias of 0.01 with an agreement limit of (-0.28, 0.31).This suggests that the CBCT and 
OBI do not have a good agreement with each other. 
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Figure:  4. 11 : The Bland-Altman plot between the CBCT and OBI in the z direction   
Table 4.2.3.1 and Figure 4.11 the Bland–Altman plot for the systematic error in the z direction 
showed a bias of -0.20 with an agreement limit of (-0.80, 0.41). This suggests that the CBCT and 
OBI do not have a good agreement with each other. One patient was out of the limits. 
 
 
  CBCT 
 
   OBI   
            
 Minimum 
 
 
 
Median Maximum   Minimum Median Maximum  p 
Value 
            
Sys 
error 
x 
0.10 
 
 
 
0.30 0.60   0.00 0.13 0.70  0.10 
Sys 
error 
y 
0.03 
 
 
 
0.20 0.90   0.00 0.23 1.10  0.68 
Sys 
error 
z 
0.03 
 
 
 
0.33 1.80   0.00 0.23 1.30  0.03 
 
Table 4.2.3.2: The Systematic Error had a value of 0.03 which was significant in the z direction. 
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Figure: 4. 12 : Comparison of CBCT and OBI systematic errors in x direction in cm. 
Comparison between systematic errors in CBCT and OBI in the x direction showed that two 
patients in CBCT and one patient in the OBI exceeded the tolerance of 5mm as depicted in the 
Figure 4.12. 
 
 
Figure:  4. 13: Comparison of CBCT and OBI systematic errors in y direction in cm. 
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Comparison between systematic errors in CBCT and OBI in the y direction showed that one 
patient in the CBCT and two patients in the OBI exceeded the tolerance of 5mm as depicted in 
the Fig. 4.13. 
.  
Figure:  4. 14: Comparison of CBCT and OBI systematic errors in z direction in cm. 
Comparison between the systematic errors of CBCT and OBI in the z direction showed that 5 
patients in CBCT and 3 patients in OBI exceeded the tolerance limits of 5 mm as shown in Fig 
4.14. 
4.2.4 CONE BEAM COMPUTED TOMOGRAPHY 
4.2.4.1 RANDOM ERRORS: 
Definition:  They are deviations between different fractions, during a treatment series which are 
a result of day to day variation in patient position and organ motion or otherwise called treatment 
execution errors. 
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Patient No: x[cm] y[cm] z[cm] Radial Error 
1 0.15 0.10 0.24 0.3 
2 0.12 0.21 0.15 0.277 
3 0.17 0.26 0.12 0.33 
4 0.09 0.18 0.18 0.27 
5 0.16 0.22 0.22 0.34 
6 0.23 0.36 0.14 0.44 
7 0.10 0.38 0.16 0.47 
8 0.17 0.47 0.63 0.80 
9 0.31 0.31 0.51 0.67 
10 0.15 0.56 0.40 0.70 
11 0.12 0.27 0.47 0.55 
12 0.71 0.45 0.16 0.85 
13 0.13 0.26 0.25 0.38 
14 0.17 0.46 0.36 0.60 
15 0.47 0.32 0.30 0.48 
Mean 0.2168 0.3079 0.3032 0.6853 
SD 0.1657 0.1289 0.4156 0.45318 
Min 0.09 0.10 0.12 0.18 
Max 0.71 0.56 0.63 1.82 
Percentile Quantiles 
25
th
 0.1225 0.2128 0.1590 0.3944 
50
th
[median] 0.1633 0.2693 0.2539 0.6633 
75
th 
0.2279 0.4466 0.4197 0.8876 
 
Table 4.2.4.1: Random Errors in cm in x, y and z direction and radial errors using CBCT 
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Figure: 4. 15: Random Errors measured by CBCT in cm in x, y and z directions for the 15 
patients. 
 
The random errors of the CBCT ranged from 0.09 to 0.71cm in the x direction, 0.10 to 0.56cm in 
the y direction and 0.12 to 0.63cm in the z direction respectively. The shift exceeded the 
tolerance in 1 patient in x direction, 1 patient in the y direction and 2 patients in z direction. The 
median shift and shift in 75
th
 percentile were within the tolerance.  
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Figure: 4. 16: Random Errors measured by CBCT in the x direction in cm  
Figure 4.16 shows the histogram of the random errors of CBCT in the mediolateral direction and 
the graph shows that most of the errors were within 0.5cm. One patient had an error of more than 
0.5cm (0.71cm). 
 
Figure: 4. 17: Random Errors measured by CBCT in the y direction in cm  
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Figure 4.17 shows the histogram of the random errors of CBCT in the craniocaudal direction and 
the graph shows that most of the errors were within 0.5cm except for one patient who had an 
error of 0.56cm. The graph represents a normal distribution. 
 
Figure: 4. 18: Random Errors measured by CBCT in the z direction in cm  
Figure 4.18 shows a histogram of the random errors of CBCT in antereoposterior direction and 
the graph shows that 13 patients had errors within 0.5cm, 2 patients had an error of 0.51 and 
0.63cm. 
4.2.4.2 POPULATION RANDOM ERROR CBCT 
Random Error No of Patients Population Random Error σset-up 
x 15 0.22 
y 15 0.31 
z 15 0.30 
Table 4.2.4.2: Population Random Error [set up] using CBCT 
The population random errors were 0.22, 0.31 and 0.30 in the x, y and z direction. 
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4.2.5 ON BOARD IMAGER 
4.2.5.1 RANDOM ERRORS 
Patient No. x [cm] y [cm] z [cm] Radial Error 
1 0.34 0.31 0.32 0.56 
2 0.11 0.13 0.17 0.240 
3 0.21 0.17 0.31 0.411 
4 0.39 0.21 0.24 0.503 
5 0.24 0.23 0.00 0.332 
6 0.25 0.25 0.07 0.360 
7 0.09 0.17 0.30 0.356 
8 0.25 0.57 0.39 0.734 
9 0.23 0.17 0.30 0.414 
10 0.24 0.48 0.00 0.536 
11 0.11 0.28 0.36 0.469 
12 0.22 0.22 0.27 0.411 
13 0.11 0.22 0.26 0.357 
14 0.24 0.54 0.46 0.748 
15 0.47 0.25 0.29 0.611 
Mean 0.2333 0.2814 0.2501 0.5566 
SD 0.1054 0.1740 0.1732 0.2427 
Min 0.09 0.13 0.00 0.0 
Max 0.47 0.57 0.46 1.31 
Percentile Quantiles 
25
th
 0.1130 0.1740 0.1732 0.2427 
50
th
[median] 0.2398 0.2345 0.3140 0.4558 
75
th 
0.2489 0.3140 0.3193 0.7789 
 
Table 4.2.5.1: Random and Radial Errors in cm in the x, y and z directions by OBI 
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Figure:  4. 19: Random Error displacements in cm in the x, y and z direction for all 15 
patients using OBI. 
The Random Errors of the OBI ranged from 0.09 to 0.47cm in the x direction, 0.13 to 0.57cm in 
the y direction and 0.0 to 0.46cm in the z direction respectively as shown in Table 4.2.5.1. The 
maximum error was seen in one patient of 0.57cm in the y direction. The median shift and shift 
in 75
th
 percentile were within the tolerance in all three directions.  
 
4.2.5.2 POPULATION RANDOM ERROR OBI 
Random Error No of Patients Population Random Error σset-up 
x 15 0.23 
y 15 0.28 
z 15 0.25 
Table 4.2.5.2: Population Random Error [set up] using OBI 
The population random errors were 0.23, 0.28 and 0.25 in the x, y and z direction respectively. 
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Figure 4.20: Random errors measured by OBI in the x direction in cm  
Figure 4.20 shows a histogram of the random errors of OBI in mediolateral direction and the 
graph shows that all 15 patients had errors within 0.5cm. 
 
Figure 4.21: Random errors measured by OBI in the y direction in cm  
Figure 4.21 shows a histogram of the random errors of OBI in craniocaudal direction and the 
graph shows that 14 patients had errors within 0.5cm, 1 patient had an error of 0.57. 
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Figure 4.22: Random errors measured by OBI in the z direction in cm  
Figure 4.22 shows a histogram of the random errors of OBI in antereoposterior direction and the 
graph shows that all 15 patients had errors within 0.5cm. 
4.2.6 COMPARISON OF CBCT AND OBI RANDOM ERRORS 
 CBCT Vs   OBCT  BIAS[SD]  Limits of Agreement 
[LL, UL] 
 
      Random error(x) 
 
 
 
0.02[0.17]  [-0.31, 0.35]  
     Random error(y) 
 
 
 
0.03[0.11]  [-0.25, 0.19]  
Random error(z) 
 
 
 
-0.05[0.16]  [-0.36, 0.26] 
Table 4.2.6.1: Shows the Bias and the limits of agreement between the CBCT and OBI random 
error 
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Figure: 4. 23: The Bland-Altman plot between the CBCT and OBI in the x direction.   
Table 4.2.6.1 and Figure 4.23 the Bland–Altman plot for the random error in the x direction 
showed a bias of 0.02 with an agreement limit of (-0.31, 0.35). This suggests that the CBCT and 
OBI do not have a good agreement with each other. One patient was out of the limits. 
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Figure: 4. 24: The Bland-Altman plot between the CBCT and OBI in the y direction     
Table 4.2.6.1 and Figure 4.24 the Bland–Altman plot for the random error in the y direction 
showed a bias of 0.03 with an agreement limit of (-0.25, 0.19).This suggests that the CBCT and 
OBI do not have a good agreement with each other. Two patients were not within the limits. 
 
Figure:  4. 25: The Bland-Altman plot between the CBCT and OBI in the z direction   
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Table 4.2.6.1 and Figure 4.25 the Bland–Altman plot for the random error in the y direction 
showed a bias of -0.05 with an agreement limit of (-0.36, 0.26). This suggests that the CBCT and 
OBI do not have a good agreement with each other. One patient was not within the limits. 
  CBCT 
 
   OBI   
         
 Minimum 
 
Median Maximum  Minimum Median Maximum p Value 
         
Ran err x 0.09 
 
0.16 0.71  0.09 0.23 0.47 0.25 
Ran err y 0.10 
 
0.26 0.56  0.13 0.23 0.57 0.25 
Ran err z 0.12 
 
0.25 0.63  0.00 0.31 0.46 0.28 
         Table 4.2.6.2: The p value was not statistically significant for Random Errors in any direction [p 
value of  0.05 was taken as significant]. 
 
 
Figure: 4. 26: Comparison of CBCT and OBI random errors in the x direction in cm 
The comparison between the CBCT and the OBI random errors in the x direction showed that 
only one patient in the CBCT was above the tolerance of 5mm as shown in figure 4.26 
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Figure: 4. 27: Comparison of CBCT and OBI random errors in the y direction in cm. 
The comparison of the CBCT and the OBI random errors in the y direction showed that one 
patient  in CBCT and two patients in OBI were above the tolerance of 5mm as shown in Figure 
4.27.  
 
Figure: 4. 28: Comparison of CBCT and OBI Random Errors in the z direction in cm 
The comparison between the CBCT and the OBI Random Errors in the z direction showed only 
one patient in the CBCT more than the tolerance of 5 mm as shown in Figure 4.28. 
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4.2.7 VECTOR DISPLACEMENT 
4.2.7.1 SYSTEMATIC RADIAL ERROR: CBCT 
 
 
Figure:  4. 29: CBCT: Length of the Mean Vector Displacement in cm 
Figure 4.29 show that the Radial Systematic Errors ranged from 0.18 to 1.82cm for the CBCT  
 
4.2.7.2 SYSTEMATIC RADIAL ERROR: OBI 
 
  
 Figure: 4. 30: OBI: Length of the Mean Vector Displacement in cm 
E
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The radial errors as shown in Fig 4.30 show that the Radial Systematic Errors ranged from 0.0 to 
1.31cm for the OBI. 
4.2.7.3 RANDOM RADIALERRORS: CBCT 
 
 
Figure:  4. 31: CBCT: Length of the mean vector displacement in cm 
The Radial Random Errors shown in Figure 4.31 ranged from 0.27 to 0.85cm in CBCT. 
 
4.2.7.4. RANDOM RADIALERRORS: OBI 
 
 
Figure: 4. 32: OBI: Length of the mean vector displacement in cm 
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The Radial Random Errors shown in Figure 4.32 ranged from 0.24 to 0.74cm in OBI. 
4.2.8 COMPARISON OF RADIAL ERRORS BETWEEN CBCT AND OBI 
4.2.8.1 SYSTEMATIC ERRORS 
 
Figure: 4. 33: Comparison of the Radial Systematic Errors between CBCT and OBI. 
The Radial Systematic Errors were compared between the OBI and CBCT and Figure 4.33 
shows trend of errors between the two modalities. This figure shows that the CBCT detected 
more number of errors than the OBI. 
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4.2.8.2 RANDOM ERRORS 
 
 
 
 
Figure: 4.34  Comparison of the Radial Random Errors between CBCT and OBI 
The Radial Random Errors were compared between the OBI and CBCT in the Fig 4.31 shows 
trend of errors between the two modalities. This Figure shows that CBCT detected more errors as 
compared to the OBI. 
Radial Error 
 Minimum Median Maximum P Value 
0.21 CBCT 0.18 0.66 1.82 
OBI 0.00 0.45 1.31 
Table 4.2.8.3:  Comparison between the radial errors of CBCT and OBI. 
It gives a P value of 0.21 which is not significant. [<0.05 is considered as significant] 
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Table 4.2.8.4:  Radial error between the CBCT and OBI with the Bias and the limits of 
agreement 
 
 
 
Figure: 4. 35: This shows the Bland-Altman plot for the Radial Error comparing the CBCT 
and the OBI. 
CBCT Vs  OBCT BIAS[SD] Limits of Agreement 
[LL, UL] 
Radial error -0.13[0.32] [-0.76, 0.5] 
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Table 4.3.2 and Figure 4.32 the Bland–Altman plot for the radial error between CBCT and OBI 
which showed a bias of -0.13 with an agreement limit of (-0.76, 0.5). This suggests that the 
CBCT and OBI do not have good agreement with each other. One patient was not within the 
limits.  
 
4.4 CALCULATION OF CTV TO PTV MARGIN. 
 
The calculation of the CTV to PTV margin was done using the formulas which are given below 
where  is the Population systematic error and  is the Population random error. 
 
1. Van Herk’s formula: 2.5 + 1.64  
2.  Stroom’s formula: 2 +0.7 
3.   ICRU formula:  +0.7 
  CBCT   OBI  
 
VAN HERK STROOM ICRU VAN HERK STROOM ICRU 
X 0.41 0.19 0.17 0.50 0.26 0.21 
Y 0.60 0.25 0.25 0.70 0.39 0.29 
Z 1.04 0.65 0.43 0.71 0.41 0.29 
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The above Table 4.4.1 shows that in the Van Herk formula,the margins were not adequate in the 
y and z direction and in the Stroom’s formula the margins were not adequate only in the  z 
direction.[CTV to PTV margin in our institution was taken as 0.5cm for pelvic malignancies]. 
 
 
4.5) TIME TREND ANALYSIS: 
The time trend analysis is a necessary tool to assess the changes in errors with time in turn 
enabling the adequacy of treatment.  
This was calculated as an average of the total errors every week and plotted against time. 
 
 
 
 
 
 
Figure: 4. 36: This shows the time trend of CBCT versus OBI in the x direction. 
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Figure:  4. 37: This figure shows the time trend of CBCT versus OBI in the y direction. 
 
 
 
 
Figure: 4. 38: This figure shows the time trend of CBCT versus OBI in the z direction 
The time trend analysis depicts that the errors measured by CBCT and the OBI were almost 
equal in the x and y direction, but in the z direction there were more errors detected by CBCT as 
compared to the OBI. 
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6. DISCUSSION 
 
6.1. INTRODUCTION 
 
 
The set up of patients before initiation of radiation treatment is an important aspect in the 
planning process and later in the treatment process. Errors during the set up contribute to the in 
adequacy in dose delivered to the target as well as the surrounding normal organs. 
A good IG-IMRT protocol reduces these set up errors, thus resulting in a more precise set up and 
treatment delivery. We should also ensure that the modality of imaging is adequate for treatment 
verification thereby avoiding unnecessary dose to the patient with repeat imaging. 
This study was performed to compare between the two modalities of imaging, Kilo Voltage 
Cone Beam CT [KV CBCT] and the On Board Imager [OBI] which are used for verifying the 
position of the patient prior to treatment delivery. 
It used the 3D-3D matching and the 2D-2D matching respectively. The systematic and the 
random errors were calculated based on the shifts noted. According to the ICRU,  the CTV to 
PTV margins should represent the real dose in the “moving” Clinical Target Volume(31). 
The calculations of CTV to PTV margin based on the Systematic and the Random Errors were 
proposed by various authors but it is important for each institution to have its own protocol for 
the same. This study also aims to calculate the CTV to PTV margins based on the 2 modalities of 
treatment verification. 
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6.2. ERRORS 
6.2.1. CONE BEAM CT SCAN 
 
Studies have been done in pelvic malignancies on set up errors. Kim et al showed Systematic 
Errors of  0.21, 0.12  and 0.22cm and the Random Errors of 0.48, 0.30 and 0.38cm with CBCT in 
the mediolateral [ML], craniocaudal [CC] and antereoposterior [AP] directions  respectively(39). 
Palombarini M et al(40) analysed the shifts using the kV CBCT and the Systematic Errors were 
<0.1cm in the ML and the CC directions, but 0.32cm in the  AP direction. The Random Errors 
were also more in AP direction as compared to the ML and CC direction. 
A study done by Zaghloul MS et al on CBCT showed Systematic Errors of 0.21 (±0.12), 0.30 
(±0.21) and 0.22 (±0.18)cm and Random Errors of 0.21 (±0.16),  0.24 (±0.18) and 0.23 
(±0.18)cm in the ML, CC and AP directions respectively(41). 
Vanasek J et al(21)  performed a study on adaptive image guided intensity modulated radiation 
therapy using kV CBCT and kV- kV imaging. More errors were seen in the AP direction with 
shifts of ≥0.2cm in 43% and ≥0.5cm in 9% of the patients. He proposed that integrating CBCT 
and kV-kV imaging in the IG-IMRT protocol provided adequate coverage of the target. 
The study done by Kataria et al(42) to assess set up error using kV x- ray volume imaging in 
abdominal malignancies showed Systematic Errors of 0.11, 0.3 and 0.13cm and Random Errors 
of 0.2, 0.48 and 0.19cm in the ML, CC and AP directions respectively and a mean vector 
displacement of 0.35cm . 
In our study the mean Systematic Errors calculated in the mediolateral [ML], craniocaudal [CC] 
and antereoposterior [AP] directions were 0.29 (±0.14), 0.2 (±0.45) and 0.50cm (±0.21) 
respectively as shown in Table 4.2.1.1  
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The Population Systematic Errors were 0.02, 0.04 and 0.22 cm in the ML, CC and AP directions 
respectively as shown in Table 4.2.1.2. The mean vector displacement for the population was 
0.69 (±0.45) as shown in Table 4.2.1.1. 
The Random Errors calculated in the ML, CC and AP directions were 0.21 (±0.1657), 
0.30(±0.1289) and 0.30 (±0.1560) cm respectively as shown in Table 4.2.4.1 
The Population Random Errors were 0.21, 0.30 and 0.30cm in the ML, CC and AP directions 
respectively as shown in Table 4.2.4.2. The mean vector displacement for the population was 
0.6853(±0.4531) as shown in Table 4.2.4.1 
The results of our study were correlating with results obtained from the other studies (3,4,5,6) 
and they were all within the tolerance limits of 0.5cm. Systematic Errors detected by the CBCT 
were more in the antereoposterior [AP] direction.  
6.2.2. ON BOARD IMAGER 
A study done by Adamcyzk  et al on position correction strategies on patients with prostate 
cancer on IMRT with kV 2D-2D matching showed errors of -0.06 (± 0.47), 0.26 (± 0.38) and  
-0.11 (±0.54)cm in the ML, CC and AP directions respectively(35). 
Studies in gynecological malignancies by Kim et al(39) showed Systematic Errors of 0.24, 0.25 
and 0.10cm and Random Errors of 0.5, 0.38 and 0.4cm in the ML, CC and AP directions. 
Logadottir et al in his study on accuracy of prostate localization with OBI showed Systematic 
Errors of 0.01, 0.007 and 0.11cm and Random Errors of 0.10, 0.12 and 0.13cm in the ML, CC 
and AP directions with OBI.  
 A study done by Zaghloul et al, to compare EPID and MV CBCT(41) in both head and neck and 
non head and neck patients showed the Systematic Errors with EPID were 0.16 (±0.13), 0.18 
(±0.17), and 0.14 (±0.15)cm and 0.16 (±0.13), 0.23 (±0.17) and 0.24 (±0.16) cm for MV-CBCT 
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in the ML,CC and AP directions respectively. Random Errors with EPID were 0.14 (±0.15), 0.20 
(±0.17) and 0.12 (±0.16) cm and 0.15 (±0.13), 0.19 (±0.15), and 0.21 (±0.17) cm for MV-CBCT 
in the ML, CC and AP directions respectively.  
Systematic Errors of head and neck patients(41) had a statistically significant difference in the 
ML and CC directions (p value of 0.027 and 0.003 respectively), whereas in the non-head and 
neck patients there was a statistically significant difference only in the ML direction (p value of 
0.031). In head and neck patients, the Random Errors were significantly different in the ML and 
CC directions, whereas in non-head and neck patients, they were significantly different in the AP 
direction only. 
In our study, the Systematic Errors calculated for OBI ranged from 0.22 (±0.21), 0.28 (±0.21) 
and 0.30 (±0.45) and the Random Errors were 0.23 (±0.10), 0.28 (± 0.17) and 0.25 (± 0.17) in the 
ML, CC and the AP directions respectively as shown in Table 4.2.2.1 and 4.2.5.1. 
The Population Systematic Error calculated for OBI was 0.05, 0.10 and 0.12 and 0.23, 0.28 and 
0.25cm in the ML, CC and AP directions respectively as shown in Table 4.2.2.2 and 4.2.5.2. 
The results of our study were correlating with results obtained from the other studies and they 
were all within the tolerance limits of 0.5cm.The errors obtained in OBI were lower as compared 
to CBCT. 
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6.2.3. COMPARISON BETWEEN CBCT AND OBI 
 
The expected uncertainty during inter-fraction treatment in abdomen and pelvic malignancies is 
considered as 4.5 to 7mm according to the AAPM task group 2011(43). 
A margin of 5mm is considered as the tolerance limit and an error ≥5mm is considered as error 
which warrants correction prior to IMRT treatment in pelvic malignancies in our Institution. 
A study by Lim et al done on pelvic IMRT for carcinoma cervix patients supported that a 0.5cm 
CTV to PTV margin would be adequate(44).  
Kim et al in their study on evaluation of set up errors using daily kilo voltage imaging arrived at 
a Van Herk margin of 0.7, 0.62 and 0.53cm in the ML, CC and AP directions. But as per their 
institutional protocol they were within the tolerance limits(39). 
Bondar et al, proposed a margin of 5mm in cervical malignancies on IMRT(45).  
In our study the comparison of the Systematic Errors between CBCT and OBI showed that 2 
patients in the CBCT and one patient in the OBI in the ML direction [Fig 4.12], 1 patient in the 
CBCT and 2 patients in the OBI in the CC direction [Fig 4.13] and 5 patients in CBCT and 3 
patient in OBI exceeded the tolerance of 5mm in the AP direction [Fig 4.14].  
The comparison between the CBCT and the OBI Random Errors showed that 1 patient in the 
CBCT in the ML direction [Fig 4.26], 1 patient each in CBCT and OBI in the CC direction [Fig 
4.27] and 1 patient in the CBCT in the AP direction [Fig 4.28] exceeded the tolerance of 5mm. 
On comparison, the Systematic Errors in CBCT were more compared to OBI which suggests that 
CBCT detected more errors than OBI due to better soft tissue matching. The Random Errors 
were comparable between the two modalities. 
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 The Radial Systematic Errors as shown in Fig 4.29 and 4.30 ranged from 0.18 to 1.82cm for 
CBCT and 0.0 to 1.31cm for OBI. The Radial Random Errors shown in Fig 4.31 and Fig 4.32 
ranged from 0.27cm to 0.85 cm in CBCT and 0.24 to 0.74cm in OBI. 
The mean vector displacement exceeded the tolerance limit both in CBCT and OBI, probably 
because 5 patients exceeded the tolerance limits of 0.5cm (0.73, 0.93, 1.80, 0.57and 0.90cm) in 
the AP direction in CBCT and 3 patients exceeded the tolerance limits of 0.5cm (0.60, 0.63 and 
1.30]) in the  AP direction in OBI.  
These depict that the overall vector length was more in the Systematic Errors as compared to 
Random errors. CBCT has the advantage of better soft tissue visualization which helps in 
detecting more errors compared to OBI which detects errors based on bony anatomy only.  
The Bland-Altman plot between CBCT and OBI did not show agreement between CBCT and 
OBI in detecting set up errors. 
Snir et al in his study on IMRT of carcinoma prostate showed that the CBCT is necessary for 
treatment verification(46). 
Palombarini et al suggested that daily kV CBCT is preferable for high dose gradient IMRT 
treatments like carcinoma rectum where there can be variable filling of the rectum and bladder 
which can lead to a geographical miss of the target(40). Another study by Kim et al comparing 
CBCT and OBI in gynecological malignancies showed that verification of set up errors were not 
statistically significant between the 2D-2D imaging and the 3D-3D imaging(39). 
CBCT and OBI are two modalities which cannot be compared but when used together gives an 
additional advantage of both soft tissue and bony anatomy ensuring improved accuracy of 
treatment delivery. 
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6.2.4. CTV TO PTV MARGIN 
 
 
The CTV to PTV margin was calculated by the 3 formulae as given in the literature (8, 9). 
1. Van Herk’s formula: 2.5 + 1.64  
2.  Stroom’s formula: 2 +0.7 
3.   ICRU formula:  +0.7 
where  is the Population Systematic Error and   Population Random Error 
 
 
 
In the study by Van Herk et al the CTV to PTV margins were calculated for CBCT and OBI. The 
margins calculated by the Van Herk’s formula were 0.25 and 0.21, by Stroom’s formula it was 
0.17 and 0. 14 and by ICRU it was 0.10 and 0.08 cm for CBCT and OBI respectively (47). 
The CTV to PTV margins calculated using Van Herk’s formula in gynecological malignancies 
were found to be 0.91, 0.83 and 0.55 cm in ML, CC and AP directions according to Lim et 
al(39).   
 
 
In our study the comparison between CBCT and OBI by Van Herk’s formula showed a margin 
of 0.41, 0.60 and 1.04cm and 0.5, 0.7 and 0.71cm in the ML, CC and AP directions respectively. 
The margin calculated by Stroom’s formula was 0.19, 0.23 and 0.65cm by CBCT and 0.26, 0.39 
and 0.41cm by OBI in the ML, CC and AP directions respectively.  
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The margin calculated by the ICRU formula were 0.17, 0.25 and 0.43cm by CBCT and 0.21, 
0.29 and 0.29cm by OBI  in the ML, CC and AP directions respectively as shown in Table 4.4.1. 
In comparison with the other studies (1, 3, 5) our margins were within the limits of 0.5cm, in 
majority of patients as per the Institutional protocol where the CTV to PTV margin was 
considered as 0.5cm. The margin exceeded to a maximum of 1.04cm in the AP direction by 
CBCT and a maximum of 0.7cm in the CC and AP direction by the OBI.  
 
 
 
6.2.5. TIME TRENDS 
 
 
The impact of time on treatment plays an important role in determining the frequency of imaging 
modality to detect set up errors. The increased anxiety and rigid posture of the patient during the 
initial treatment causes more set up errors. These may persist for the first few treatments and as 
this tension is relieved and the muscles begin to relax, and the patient can have smaller 
displacements to any direction which have to be checked by weekly imaging. This greatly 
influences the set up accuracy. Checks not only at the start of the treatment are suggested but 
repeated checks have to be continued to ensure set up accuracy. 
In our study there was a time trend seen where the errors gradually decreased in most of the 
patients, except during the 7
th
 week of treatment in the mediolateral direction alone. 
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         6.2.6. LIMITATIONS OF THE STUDY 
 
 
 The sample size is small to formulate an acceptable CTV to PTV margin to convert to an 
Institutional protocol. 
 
 The inclusion criteria included all the patients with any pelvic malignancy on IG-IMRT, 
so this will only give the overall general set up errors in pelvic malignancies and not for 
any specific malignancy. 
 
 The Body Mass Index (BMI) of a patient was not considered for the analysis which could 
have contributed to the shifts or displacements during set up. 
 
 Inter observer variation might have influenced the Errors caused during the set up of the 
patient due to different personnel treating the patient on various days and that was not 
taken into account in this study. 
   6.2.7. RECOMMENDATION 
 
 
 Similar studies on a larger sample size to determine the CTV to PTV margin and to 
standardize it for individual Institutions. 
 A site specific subset analysis of the pelvic malignancies to determine the set up errors for 
various sites and to determine the CTV to PTV margin.eg: Prostate, Cervix 
 Documentation and calculating the BMI of each patient and analyzing it as a predictor 
variable in the statistical analysis in further studies. 
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 It would be preferable to have one personnel treating the patient everyday to reduce inter 
observer variation and also keep the patient comfortable. 
     7. CONCLUSIONS  
   
 Cone Beam Computed Tomography (CBCT) and On Board Imager (OBI) are effective 
tools for determining the Systematic, Random and Radial set up errors. 
 
 Comparison of the CBCT and the OBI showed that CBCT detected more errors than the 
OBI in pelvic malignancies in patients on IG-IMRT due to better soft tissue detection. 
The two modalities cannot be compared with each other and cannot replace each other 
but have to be used symbiotically and appropriately according to the type of malignancy. 
 
 The CTV to PTV margin followed in the Institution seemed adequate in the sample size 
studied though it is small. This knowledge reassures the Clinician that accurate treatment 
delivery is being done. 
 
 The errors were found to be decreasing over time, as patients became comfortable and 
familiar with the treatment set up, showing a time trend leading to improved accuracy in 
set up. This again reassures that weekly imaging or even less is sufficient in the later 
weeks of radiotherapy. 
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                                        ANNEXURE I 
                                        Christian Medical College, Vellore 
                                                      Department of Radiotherapy  
An observational study to compare the OBI and CBCT in verifying the patient position during 
pelvic IMRT 
Information sheet 
You are being requested to participate in a study to verify your position during treatment by 
taking an OBI[a form of X-ray] and a CT scan [CBCT-cone beam CT] .There are no extra side 
effects except for negligible amount of radiation you will receive during the OBI. We hope to 
include about 30 people from this hospital in this study. 
What does OBI do? 
We regularly do CT scans in the first 3 days and then weekly once to check your position during 
treatment to make sure the treatment is delivered correctly. Now we also do an additional OBI 
[X-ray] to verify your position as an additional check. 
 Does OBI have any side effects? 
OBI is a form of X-ray which has a negligible amount of radiation of about 2 Mu which will not 
cause any side effects 
If you take part what will you have to do? 
If you agree to participate in this study every day   after you are positioned for treatment both 
OBI and CBCT will be taken to verify your position. Once ensured that your position is correct 
the treatment will be carried out. This will be done for the first 3 days of your treatment and 
then weekly once till the end of treatment. 
 Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to decide to withdraw 
permission to participate in this study. If you do so, this will not affect your usual treatment at 
this hospital in any way.  
Will you have to pay for the OBI? 
The OBI will be done at no additional cost to your regular radiotherapy expenses. 
What happens after the study is over? 
You will have to just complete your treatment and can be on follow up as per the advice of your 
oncologist. 
Will your personal details be kept confidential? 
The results of this study may be published in a medical journal but you will not be identified by 
name in any publication or presentation of results. However, your medical notes may be 
reviewed by people associated with the study, without your additional permission, should you 
decide to participate in this study. 
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                                            INFORMED CONSENT 
 
Study Title: observational study to compare the OBI and CBCT in verifying the patient position 
during pelvic IMRT 
 
Study Number: 
Participant’s name:  
Date of Birth / Age (in years): 
 
I_____________________________________________________________ 
___________, son/daughter/wife of  ___________________________________ 
 
(Please tick boxes) 
Declare that I have read the information sheet provide to me regarding this study and have 
clarified any doubts that I had. [ ] 
I also understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting my usual 
treatment or my legal rights [ ] 
I understand that my identity will not be revealed in any information released to third parties or 
published [ ]   
I voluntarily agree to take part in this study [ ] 
 
Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
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                                            ANNEXURE II 
 
CLINICAL RESEARCH FORM 
 Name : 
 
 Age: 
 Sex: 
 
 Address: 
 
 
 
 
 Phone No:   
 Mobile No: 
 Landline No: 
 
 Diagnosis and stage: 
 
 Treatment: Radiation alone [   ]         Chemotherapy +RT [  ] 
 
 Dose of radiation: 
 
 Duration of RT: 
 
 Date of starting RT: 
 
 Date of completion of RT: 
 
 No: of OBIs done: 
 No: CBCT done: 
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                                        ANNEXURE III 
                                                        
                                               SHIFT SHEET 
Name:                              Hospital Number:                        Diagnosis: 
 
Date CBCT 
ML 
[X] 
OBI 
ML 
[X] 
CBCT 
CC 
[Y] 
OBI 
CC 
[Y] 
CBCT 
AP 
[Z] 
OBI 
  AP 
[Z] 
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                                         ANNEXURE V 
                    PLAGIARISM RECEIPT AND REPORT 
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